NASDAQ:AUPH (Aurinia Pharmaceuticals)
About AUPH
Aurinia Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.
Aurinia Pharmaceuticals (NASDAQ: AUPH) Latest News
Coronavirus
3 TSX Stocks Bay Street Expects Could Double or Triple in 1 Year!
Investing
Value Investors: 1 Pharma Growth Stock With Huge Potential
Stocks for Beginners
3 Top Canadian Pharma Stocks for Ambitious Investors
Top TSX Stocks
3 BioPharm Stocks Yielding 100% Yearly Returns
Investing
3 Stocks That Could Benefit From Canada’s Population Boom
Investing
Which Canadian Healthcare Stocks Could Make You Rich?
Investing
This Unloved Drug Stock Could Have Massive Upside
Investing
3 High-Performing Stocks to Buy on the Dip
Investing
TSX Reaches 16,000: These Are 5 of the Highest-Performing Stocks This Year
Dividend Stocks
3 Stocks That Have Soared Higher Than Shopify Inc. This Year!
❮2